Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01515475 · ClinicalTrials.gov registry record · NA

Hyperopia Treatment Study 1 (HTS1) - Glasses vs Observation

A NA study of Hyperopia, sponsored by Jaeb Center for Health Research.

Completed
Registry status
NA
Development phase
249
Enrollment target
2
Study locations

NCT01515475 is a NA study of Hyperopia that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 249 participants, above the 99-participant average among 10 other Hyperopia trials with a reported enrollment target (152% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01515475, a NA study of Hyperopia, has completed, sponsored by Jaeb Center for Health Research.

COMPLETED
Registry status
NA
Development phase
249 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to compare visual acuity outcomes and development of strabismus after a 3-year follow-up period in children age 12 to \<72 months with moderate hyperopia (spherical equivalent +3.00D to +6.00D) who are prescribed glasses either immediately or only after confirmation of pre-specified deterioration criteria.

Conditions Studied

Interventions

  • PROCEDURE Glasses

Study Locations (2)

Ohio

  • The Ohio State University College of Optometry - Columbus

Utah

  • Rocky Mountain Eye Care Associates - Salt Lake City

Trial Details

FieldValue
Enrollment Target 249 participants
Start Date 2012-02-23
Est. Completion 2018-02
Phase NA

Sponsor

Jaeb Center for Health Research

119 total trials

What the Registry Record Tells You About NCT01515475

The ClinicalTrials.gov registry entry for NCT01515475 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 249 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 99-participant average among 10 other Hyperopia trials with a reported enrollment target (152% higher). The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hyperopia appearing as the primary indexed condition, and to 1 intervention - of which Glasses is the first listed.

NCT01515475 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Ohio, Utah.

Frequently Asked Questions

What is clinical trial NCT01515475 about?

NCT01515475 is a clinical study titled "Hyperopia Treatment Study 1 (HTS1) - Glasses vs Observation". The purpose of this study is to compare visual acuity outcomes and development of strabismus after a 3-year follow-up period in children age 12 to \<72 months with moderate hyperopia (spherical equivalent +3.00D to +6.00D) who are prescribed glasses either immediately or only after confirmation of p...

What is the current status of trial NCT01515475?

This trial is currently completed. It is a NA study. The enrollment target is 249 participants. The study started on 2012-02-23. Estimated completion is 2018-02.

What conditions does trial NCT01515475 study?

This clinical trial studies the following conditions: Hyperopia.

What interventions are being tested in trial NCT01515475?

The interventions under investigation include: Glasses (PROCEDURE).

Who is sponsoring clinical trial NCT01515475?

This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01515475 being conducted?

This trial has 2 study locations across Ohio, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hyperopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.